1. Immune Checkpoint Inhibition as Single Therapy for Synchronous Cancers Exhibiting Hypermutation: An IRRDC Study. (2nd March 2022) Authors: Henderson, Jacob J.; Das, Anirban; Morgenstern, Daniel A.; Sudhaman, Sumedha; Bianchi, Vanessa; Chung, Jill; Negm, Logine; Edwards, Melissa; Kram, David E.; Osborn, Michael; Hawkins, Cynthia; Bouffet, Eric; Cho, Yoon-Jae; Tabori, Uri Journal: JCO precision oncology Issue: Volume 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. MYCN Amplified Relapse Following Resolution of MYCN Nonamplified 4S Neuroblastoma With Placental Involvement: A Case Report and Review of the Literature. Issue 5 (July 2019) Authors: Langenberg-Ververgaert, Karin P.S.; Renzi, Samuele; Chung, Catherine T.; Shago, Mary; Lo, Winnie; Davidson, Scott; Villani, Anita; Baruchel, Sylvain; Irwin, Meredith S.; Morgenstern, Daniel A. Journal: Journal of pediatric hematology/oncology Issue: Volume 41:Issue 5(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Outpatient administration of naxitamab in combination with granulocyte‐macrophage colony‐stimulating factor in patients with refractory and/or relapsed high‐risk neuroblastoma: Management of adverse events. Issue 1 (17th May 2022) Authors: Mora, Jaume; Chan, Godfrey C.; Morgenstern, Daniel A.; Nysom, Karsten; Bear, Melissa K.; Tornøe, Karen; Kushner, Brian H. Journal: Cancer reports Issue: Volume 6:Issue 1(2023) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Pain mitigation and management strategies for anti‐GD2 infusions: An expert consensus. Issue 5 (11th February 2023) Authors: Nysom, Karsten; Morad, Andrea Gomez; Rafael, Margarida Simão; Zier, Judith; Marachelian, Araz; Watt, Tanya; Morgenstern, Daniel A. Journal: Pediatric blood & cancer Issue: Volume 70:Issue 5(2023) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Phase I study of vinblastine and sirolimus in pediatric patients with recurrent or refractory solid tumors. Issue 1 (17th August 2013) Authors: Morgenstern, Daniel A.; Marzouki, Monia; Bartels, Ute; Irwin, Meredith S.; Sholler, Giselle L.S.; Gammon, Janet; Yankanah, Rosanna; Wu, Bing; Samson, Yvan; Baruchel, Sylvain Journal: Pediatric blood & cancer Issue: Volume 61:Issue 1(2014:Jan.) Page Start: 128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Phase I study of vinblastine and temsirolimus in pediatric patients with recurrent or refractory solid tumors: Canadian Cancer Trials Group Study IND.218. Issue 3 (4th November 2018) Authors: Deyell, Rebecca J.; Wu, Bing; Rassekh, S. Rod; Tu, Dongsheng; Samson, Yvan; Fleming, Adam; Bouffet, Eric; Sun, Xiaoqun; Powers, Jean; Seymour, Lesley; Baruchel, Sylvain; Morgenstern, Daniel A. Journal: Pediatric blood & cancer Issue: Volume 66:Issue 3(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Post‐thaw viability of cryopreserved peripheral blood stem cells (PBSC) does not guarantee functional activity: important implications for quality assurance of stem cell transplant programmes. (12th June 2016) Authors: Morgenstern, Daniel A.; Ahsan, Gulrukh; Brocklesby, Margaret; Ings, Stuart; Balsa, Carmen; Veys, Paul; Brock, Penelope; Anderson, John; Amrolia, Persis; Goulden, Nicholas; Cale, Catherine M.; Watts, Michael J. Journal: British journal of haematology Issue: Volume 174:Number 6(2016) Page Start: 942 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Prognostic significance of pattern and burden of metastatic disease in patients with stage 4 neuroblastoma: A study from the International Neuroblastoma Risk Group database. (September 2016) Authors: Morgenstern, Daniel A.; London, Wendy B.; Stephens, Derek; Volchenboum, Samuel L.; Simon, Thorsten; Nakagawara, Akira; Shimada, Hiroyuki; Schleiermacher, Gudrun; Matthay, Katherine K.; Cohn, Susan L.; Pearson, Andrew D.J.; Irwin, Meredith S. Journal: European journal of cancer Issue: Volume 65(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor. Issue 3 (7th October 2022) Authors: Lerman, Benjamin J.; Li, Yimei; Carlowicz, Cecilia; Granger, Meaghan; Cash, Thomas; Sadanand, Arhanti; Somers, Katherine; Ranavaya, Aeesha; Weiss, Brian D.; Choe, Michelle; Foster, Jennifer H.; Pinto, Navin; Morgenstern, Daniel A.; Rafael, Margarida Simão; Streby, Keri A.; Zeno, Rachel N.; Mody, ... Journal: Journal of clinical oncology Issue: Volume 41:Issue 3(2023) Page Start: 508 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Residual meta‐iodobenzyl guanidine (MIBG) positivity following therapy for metastatic neuroblastoma: Patient characteristics, imaging, and outcome. Issue 12 (19th August 2021) Authors: Usmani, Nida; Deyell, Rebecca J.; Portwine, Carol; Rafael, Margarida Simao; Moorehead, Paul C.; Shammas, Amer; Vali, Reza; Farfan, Mateo; Vanniyasingam, Thuvaraha; Morgenstern, Daniel A.; Irwin, Meredith S. Journal: Pediatric blood & cancer Issue: Volume 68:Issue 12(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗